Tina Dysgaard

Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial

Jeffrey A. Allen, Jie Lin, Ivana Basta et al. · The Lancet Neurology · 2024 · 96 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +8

Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study

Luís Querol, de Sèze, Tina Dysgaard et al. · Journal of Neurology Neurosurgery & Psychiatry · 2024 · 23 citations · Full text

Medicine, Neurology, Pharmacotherapy +14

Hypokalemic periodic paralysis: a 3-year follow-up study

Sonja Holm‐Yildiz, Thomas Krag, Nanna Witting et al. · Journal of Neurology · 2023 · 11 citations · Full text

Medicine, Neurology, Neuromuscular Disorders +15